SPECIALIZED
VENTURES
Scientist-advisors for scientist-inventors specializing in computational drug discovery
OVERVIEW
Bellows Capital Partners is a specialized firm offering differentiated support to computational drug discovery companies. We are scientist-advisors for scientist-inventors. We specialize in seeing commercial opportunities in research technologies and helping scientists and entrepreneurs grow innovations out of the research lab.
Bellows Capital supports computational (e.g., AI/ML) technologies that can provide an immediate and tangible efficiency to the drug discovery process, ranging from target discovery to development. These technologies often move the “wet” lab to the computer.
​
Bellows produces support driven by fundamental analyses derived from scientific and commercial opportunities balanced with operational, regulatory, and financial risks. The Bellows Capital team’s combination of scientific, corporate, founder/operational, and financial experience allows the team to identify, execute, and realize opportunities in this specialized sector, with a specialized expertise.